Editas Medicine (EDIT) Minority Interest (2015)

Editas Medicine (EDIT) posted quarterly Minority Interest of $119.8 million for Q4 2015.

Editas Medicine (EDIT) Minority Interest (2015) Analysis & Trends

Editas Medicine (EDIT) has reported Minority Interest for 1 consecutive years, with $119.8 million the latest figure, recorded in Q4 2015.

In Q4 2015, Minority Interest changed N/A year-over-year to $119.8 million; the TTM figure through Dec 2015 stood at $119.8 million (changed N/A YoY), while the FY2015 annual figure was $119.8 million, up 476.5% from the prior year.
Minority Interest was little changed at $119.8 million in Q4 2015 per EDIT's latest filing.
Across five years, Minority Interest topped out at $119.8 million in Q4 2015 and bottomed at $119.8 million in Q4 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Editas Medicine	263.01 Mn	116.36 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2015	119.75 Mn